BEST OF SCMS
Each quarterly issue of Seminars in Cutaneous Medicine and Surgery includes in-depth discussions of interest and importance to medical and procedural dermatologists. Typically, the editors select a guest editor who organizes each issue around a specific topic. The guest editor identifies and recruits knowledgeable experts to write reviews and overviews about the state of the art in specific subject areas. The experts, in turn, address the current concepts and limits of our knowledge of the topic.
Every few years, the editors take the opportunity to look back and identify the best articles from the recent past. We select articles that we think are outstanding and worth reading again because they are so well done and considered important topics of continuing relevance.
This issue features a selection of some of the well-crafted and informative articles from recent issues, including a discussion of botulinum toxins, complications in dermatologic surgery, corticosteroid-induced osteoporosis, the relationship of isotretinoin and depression, epidermal nevus syndromes, and the treatment modalities and management options with congenital melanocytic nevi.
We hope you enjoy the look back at some of the best articles recently published in Seminars in Cutaneous Medicine and Surgery. We also invite you to plan to look forward to the information presented in future issues of this journal as we take new strides to bring you balanced, expert perspectives on advances in dermatology.
Kenneth A. Arndt, MD
Philip E. LeBoit, MD
June K. Robinson, MD
Bruce U. Wintroub, MD
Every few years, the editors take the opportunity to look back and identify the best articles from the recent past. We
select articles that we think are outstanding and worth reading again because they are so well done and considered important topics of continuing relevance.
Understanding the key aspects of preoperative assessment, the guidelines for the safe use of blood thinning agents, and
steps for management of immediate and delayed bleeding complications are crucial for minimizing patient morbidity
and maintaining good surgical outcomes.
Facial enhancement by the use of botulinum toxin has revolutionized treatment of the aging face.
In the fall of 1997, H.R., a 51-year-old white woman, thought she was receiving the optimum treatment for her
pemphigus vulgaris flares—high-dose oral prednisone (100 mg per day).
Although the efficacy of isotretinoin in treating severe or recalcitrant acne vulgaris is well established, its teratogenicity
and adverse event profile have drawn considerable attention from physicians and the public alike. Of particular concern
are reports of depression and suicidal behavior among isotretinoin users from the medical literature and the lay press.